A team of researchers from Kaunas University of Technology and Lithuanian University of Health Sciences proposed a non-invasive method for detection of melanoma. A patented computer-aided diagnostic system developed by Lithuanian scientists proved to be more than 90% accurate in detecting malignancy in diagnostic images of skin lesions acquired from 100 patients.
In Europe, melanoma is the fifth most common type of cancer and is the major cause of death from skin cancer. Northern Europe displays the largest age-standardised rate mortality of 3.8 per 10,000 in the region, with an incidence of 23.4.
Excision of a primary tumour remains essential in diagnosing melanoma, and the decision for the operation is generally based on the dermatoscopic evaluation of the lesion. However, the accuracy of melanoma clinical diagnosis is only at 65% and strongly relies on the experience of the physician-dermatologist carrying out the analysis.
“The novelty of our method is that it combines diagnostic information obtained from different non-invasive imaging technologies such as optical spectrophotometry and ultrasound. Based on the results of our research, we can confirm that the developed automated system can complement the non-invasive diagnostic methods currently applied in the medical practice by efficiently differentiating melanoma from a melanocytic mole”, says Professor Renaldas Raišutis, head of the team behind the research at Kaunas University of Technology.
In the study, carried out by the researchers of two Lithuanian universities, diagnostic images of skin lesions acquired from 100 different patients were evaluated. By comparing and analysing complex data on skin tumours recorded by different techniques, the researchers were able to develop a novel diagnostic system, differentiating melanoma from a benign nevus with accuracy higher than 90%.
“An efficient diagnosis of an early-stage malignant skin tumour could save critical time: more patients could be examined and more of them could be saved”, says Prof Raišutis.
According to Prof Raišutis, the novel diagnostic system is firstly aimed at medical professionals; he estimates that the price of the final product might be affordable even for smaller medical institutions. However, the team is also thinking about the solutions for individual use at home.
Following the research, the prototype of the technology was developed, and the clinical research is being carried out complying with the requirements of the protocol for the clinical research confirmed by the regional bioethics committee.
The invention was patented in Lithuania (Patent No. LT6670B) and the patent applications filed for Patent Cooperation Treaty and the United States Patent and Trademark Office.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Melanoma detection
- “Here’s How I Knew I Had Prostate Cancer”: One Patient’s Story of Abruptly Elevated Markers
The prostate is a small gland located in the male reproductive system that's essential for producing seminal fluid. When it's healthy, the prostate is shaped similarly to a walnut, but prostate cancer ...
- Mainz Biomed to unveil breakthrough early cancer detection study results at DDW 2024
Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, will present an analysis from its eAArly DETECT study at Digestive Disease Week (DDW) 2024 ...
- Aroostook breast cancer detection innovator vies for statewide business award
Kendra Batchelder, co-founder and CEO of Waved Medical LLC in Presque Isle, is one of two County entrepreneurs set to compete for $25,000 in the state Top Gun Showcase Pitch Event on May 16 in ...
- A blood test to help detect lung cancer? New test offered at OSF Healthcare part of trend in medicine
Julie Harris had never been tested for lung cancer. A low-dose CT scan, the only recommended screening for adults at risk of developing lung cancer, was not something she’d ever found time to do. But ...
- Lima Memorial to use AI for lung cancer detection
Lima Memorial Health System is partnering with health-technology company Eon to use artificial intelligence to review completed CT scans, X-rays, ultrasounds, MRIs and pathology reports for potential ...
Go deeper with Google Headlines on:
Melanoma detection
[google_news title=”” keyword=”melanoma detection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Melanoma
- What Are The Complications Melanoma? A Review By Doctors
Expert opinion from Ilya Aleksandrovskiy M.D., MBA · 5 years of experience · USA Common complications of melanoma include metastasis which is the most feared property of the cancer cells. It can ...
- UT Medical Center is first in Tennessee to offer newly FDA-approved melanoma treatment
The University of Tennessee Medical Center is currently the only hospital in the state to offer this type of therapy.
- Melanoma in darker skin tones: Race and sex play a role, study finds
Melanoma, an aggressive form of skin cancer that accounts for 75% of all skin-cancer-related deaths, is often detected later in people with darker skin complexions—and the consequences can be ...
- Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and NeraCare, a leading developer of laboratory tests for the prognosis of melanoma patients, announced an exclusive agreement ...
- These are the signs of acral melanoma to look out for on your fingernails, toenails, hands and feet
Acral Melanoma (ALM) is a specific type of melanoma that appears on the palms of the hands, the soles of the feet, or under the nails. It grows on the surface of the skin or under the nail bed before ...
Go deeper with Google Headlines on:
Melanoma
[google_news title=”” keyword=”melanoma” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]